For decades, dementia, especially Alzheimer’s disease, was treated as untouchable. Families watched loved ones fade, doctors could offer only reassurance and coping strategies, and research seemed to ...
NEW YORK — Alzheimer’s disease patients taking the commonly prescribed drug Aricept can benefit from it after they progress to moderate-to-severe illness, a new study says. The study also found some ...
TOKYO, July 17 (Reuters) - Japan's Eisai Co. Ltd <4523.T> on Tuesday unveiled a raft of new drug candidates in early stage trials and fleshed out plans to limit the fall-off in sales of Aricept ...
TOKYO, April 13 (Reuters) - Japanese drug maker Eisai Co. Ltd. <4523.T> said on Friday it had tentatively withdrawn its European application for its Alzheimer's drug Aricept to be also used to treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results